the first FDA-authorized Virtual Reality (VR) treatment for CLBP1

Recognized by HCPCS Code E1905

A single course of treatment delivers lasting relief of CLBP2,3

results

Study participants reported their pain levels on a scale from 0 to 10, using the DOD/VA Pain Scale. The values in parentheses are the mean reductions in pain ratings on this scale from baseline to the specified endpoints.

Explore Clinical Data
CLBP is a biopsychosocial condition
icon-smileys

People with CLBP are nearly 2-3 times more likely to experience moderate to severe depression, sleep disturbance, and require multiple medical modalities.4-7

In-home, self-guided therapeutic program which teaches skills and develops habits to help better control pain2

The 56-session curriculum includes:

timeline

Incorporates cognitive behavioral therapy (CBT) and other proven pain management techniques2

icon mindful

Mindful
Escapes

icon brain

Pain
Education

icon nose

Diaphragmatic
Breathing

icon meditate

Relaxation/
Interoceptive

Diaphragmatic Breathing

Responsive training environments enhance breathing techniques and allow you to connect with and control your nervous system response.2

Bridge the gap in treatment plans
VR Session

National guidelines acknowledge the crucial role of cognitive behavioral therapy (CBT) in the management of chronic pain and recommend its utilization as a primary intervention.8

effective for moderate to severe CLBP regardless of patient’s demographics, comorbidities, or treatment history2,9

demographicspain chart

Delivers effective pain management to patients without risk of significant side effects

No Unanticipated Adverse Device Effects (UADE) or Serious Adverse Events were observed or reported in our pivotal clinical study.2

In a later study of more than 1000 participants, 1 patient reported a serious adverse event (dizziness).9

PROGRAM EXPERIENCE
worker

Rooted in Science, Proven in Practice

icon-shield

Developed in partnership with Beth Darnall, PhD a prominent figure in pain management and behavioral medicine.

icon-satisfaction

Employing a biopsychosocial approach, the RelieVRx program integrates established cognitive behavioral therapy principles within an immersive environment, leading to significant and meaningful results.

icon-brain-border

The sequential therapeutic program promotes neuroplasticity, which helps modify regions of the brain associated with pain and delivers enduring benefit.

Dr. Beth Darnall

The way that we enhance learning with this product is that we target all of these different pathways: sensory, emotional, cognitive. It’s full brain engagement for enhanced learning.”
- Dr. Beth Darnall

Delivers significant pain reduction with both moderate and severe chronic lower back pain

In multiple double-blinded, sham-controlled clinical trials with over 1200 patients, the RelieVRx program demonstrated clinically meaningful reductions in both pain intensity and pain interference.2,10

A reduction of 2 points or more is deemed clinically significant.

top-chart
icon-vha-border

Extensively utilized by
Veterans Health Administration

Added to the Federal Supply Schedule in early 2023, the RelieVRx program is used nationwide by the Veterans Health Administration.

icon-book-border

Clinical
Resource Center

Explore the scientific evidence garnered from rigorous research and clinical studies.

Clinical Resource Center

The RelieVRx Program is Simple, Efficient, and Engaging2

The 56 therapeutic sessions have an average duration of 6 minutes.

icon thumbsup

Easier to use than an ATM

icon home

In-home and self-managed

icon vr person

Patients completed an average of 5 sessions per week

icon A+

A+ satisfaction rating from users

THERAPY SUPPORT

The RelieVRx Program offers a simple user experience

icon-rxEasy To Prescribe

The prescriber simply submits the Rx form along with the required medical documentation to the AVR Pathway support team.

icon-vr-personReady To Use

The RelieVRx device is delivered directly to the patient’s home, ready to use with preloaded content

icon-boxReturning The Device

Patients will return the device in the original packaging using the provided prepaid return shipping label.

Alleviate the Burden
icon thumbs up

The RelieVRx program minimizes injured worker and healthcare provider challenges with traditional CBT which can include the limited availability of trained therapists, travel considerations, stigma, and cost.

icon-doctor

Prescribing

It's easy to start prescribing the RelieVRx program, easy for injured workers to use, and easy for claims representatives to manage. Our prescription kit includes everything needed to get started. The prescriber simply submits the Rx form along with the required medical documentation to AVR Pathway, our support services team, and we will take care of the rest.

Length of Rental: 3 Months
Prescribing Resources:
Letter Of Medical Necessity

Include any medical documentation attachments

The AVR Pathway® team provides support for every step of the journey

The AVR Pathway team supports patients as they embark on the RelieVRx journey, serving as the primary point of contact for technical and non-medical questions.

If you are currently a RelieVRx patient and need assistance, please don't hesitate to call or email us

phone icon

We are available Monday - Friday, 9am - 7pm ET

Call: 844-728-4487

Email: support@avrpathway.com

Indication for Use The RelieVRx program is a prescription-use immersive virtual reality system intended to provide adjunctive treatment based on cognitive behavioral therapy skills and other evidence-based behavioral methods for patients (age 18 and older) with a diagnosis of chronic lower back-pain (defined as moderate to severe pain lasting longer than three months). The device is intended for in-home use for the reduction of pain and pain interference associated with chronic lower back pain.

Contraindications

There are no known contraindications.

References

  1. “Device Classification under Section 513(F)(2)(De Novo).” Accessdata.fda.gov, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=764583&lpcd=QRA.
  2. Garcia LM, Birckhead BJ, Krishnamurthy P, Sackman J, Mackey IG, Louis RG, Salmasi V, Maddox T, Darnall BD. An 8-Week Self-Administered At-Home Behavioral Skills-Based Virtual Reality Program for Chronic Low Back Pain: Double-Blind, Randomized, Placebo-Controlled Trial Conducted During COVID-19. J Med Internet Res. 2021 Feb 22;23(2):e26292.
  3. Maddox, T., Sparks, C., Oldstone, L., Maddox, R., Ffrench, K., Garcia, H., Krishnamurthy, P., Okhotin, D., Garcia, L., Birckhead, B, Sackman, J., Mackey, I., Louis, R., Salmasi, V., Oyao, A., & Darnall, BD (2023). Durable chronic low back pain reductions to 24-months post-treatment for an accessible, 8-week, in-home behavioral skills-based virtual reality program: A randomized controlled trial. Pain Medicine, in press.
  4. Yang H, Hurwitz EL, Li J, de Luca K, Tavares P, Green B, Haldeman S. Bidirectional Comorbid Associations between Back Pain and Major Depression in US Adults. Int J Environ Res Public Health. 2023 Feb 27;20(5):4217. doi: 10.3390/ijerph20054217. PMID: 36901226; PMCID: PMC10002070.
  5. Depression and Pain Comorbidity. A Literature Review. Matthew J. Bair, MD, MS; Rebecca L. Robinson, MS; Wayne Katon, MD; et al. Kurt Kroenke, MD. Author Affiliations Article Information. Arch Intern Med. 2003;163(20):2433-2445. doi:10.1001/archinte.163.20.2433
  6. Uchmanowicz I, Kołtuniuk A, Stępień A, Uchmanowicz B, Rosińczuk J. The influence of sleep disorders on the quality of life in patients with chronic low back pain. Scand J Caring Sci. 2019;33(1):119-127. doi:10.1111/scs.12610
  7. Marty M, Rozenberg S, Duplan B, Thomas P, Duquesnoy B, Allaert F; Section Rachis de la Société Française de Rhumatologie. Quality of sleep in patients with chronic low back pain: a case-control study. Eur Spine J. 2008 Jun;17(6):839-44. doi: 10.1007/s00586-008-0660-7. Epub 2008 Apr 4. PMID: 18389288; PMCID: PMC2518999.
  8. Ehde, D. M., Dillworth, T. M., & Turner, J. A. (2014). Cognitive-behavioral therapy for individuals with chronic pain: Efficacy, innovations, and directions for research. American Psychologist, 69(2), 153-166.
  9. Maddox, T., Oldstone, L., Sparks, C., Sackman, J., Oyao, A., Garcia, L., Maddox, R., Ffrench, K., Garcia, H., Irvin, A., Maislin, D., Keenan, B., Bonakdar, R., & Darnall, BD (2023). At-home virtual reality program for chronic lower back pain: A randomized sham-controlled effectiveness trial in a clinically severe and diverse sample. Mayo Clinic Proceedings: Digital Medicine, 2023;1(4):563-573.